Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 12Terminated 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1

Conditions

Somatostatinoma 1Glioblastoma 1

Interventions

Cyclophosphamide 222pembrolizumab 199Carboplatin 173Cisplatin 168Gemcitabine 167Paclitaxel 153Docetaxel 139Rituximab 137Bevacizumab 137Radiotherapy 136Dexamethasone 126Nivolumab 125Capecitabine 103fludarabine 102Pemetrexed 92fludarabine phosphate 91Fluorouracil 91Doxorubicin 85Oxaliplatin 79Etoposide 77Cytarabine 77Bortezomib 76Erlotinib Hydrochloride 74Leucovorin 72Filgrastim 68Lenalidomide 67Calcium Dobesilate 66Irinotecan 65atezolizumab 62Radiation 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Has results × irinotecan sucrosofate × Clear all
NCT03736720 2025-01-30

Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin

Roswell Park Cancer Institute

Phase 2 Terminated
11 enrolled 17 charts

Somatostatinoma

NCT03119064 2022-12-13

329

Brown University

Phase 1/2 Terminated
12 enrolled 13 charts
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡